Cart
sales@molnova.com
LJ570
CAS No. 2252488-69-8
LJ570( —— )
Catalog No. M21635 CAS No. 2252488-69-8
LJ570 is the first PPARα/γ dual agonist (PPARαPPARγ with EC50s of 1.05 and 0.12 μM respectively.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 1 mL x 10 mM in DMSO | 353 | In Stock |
|
| 2MG | 214 | In Stock |
|
| 5MG | 329 | In Stock |
|
| 10MG | 470 | In Stock |
|
| 25MG | 718 | In Stock |
|
| 50MG | 918 | In Stock |
|
| 100MG | 1274 | In Stock |
|
| 200MG | Get Quote | In Stock |
|
| 500MG | 2558 | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameLJ570
-
NoteResearch use only, not for human use.
-
Brief DescriptionLJ570 is the first PPARα/γ dual agonist (PPARαPPARγ with EC50s of 1.05 and 0.12 μM respectively.
-
DescriptionLJ570 is the first PPARα/γ dual agonist (PPARαPPARγ with EC50s of 1.05 and 0.12 μM respectively)
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayMetabolic Enzyme/Protease
-
TargetPPAR
-
RecptorPPAR
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number2252488-69-8
-
Formula Weight394.5
-
Molecular FormulaC27H22O3?
-
Purity>98% (HPLC)
-
Solubility——
-
SMILES——
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Antonio L Luca P Carmen C et al. Identification of the First PPARα/γ Dual Agonist Able to Bind to Canonical and Alternate Sites of PPARγ and to Inhibit its Cdk5-Mediated Phosphorylation[J]. Journal of Medicinal Chemistry 2018:acs.jmedchem.8b00835-.
molnova catalog
related products
-
AZD 6610
AZD 6610 is a dual peroxisome proliferator-activated receptor (PPAR) α/γ agonist for treatment of diabetes mellitus.
-
Suksdorfin
Suksdorfin has hypoglycemic effects, promotes adipocyte differentiation and enhances lipocalin production, activates peroxisome proliferator-activated receptor gamma (PPARγ), promotes insulin-dependent glucose uptake by adipocytes, and can be used to study obesity.
-
GQ-16
GQ-16 is a partial agonist of PPARγ with a Ki of 160 nM. GQ-16 reduces adipogenic actions and promotes insulin Sensitization without weight gain.
